USP2 Antibody

1. In general, we collect and summarize the factors involved in the alternative splicing of USP2 in this review to further understand the mechanism behind the USP2's alternative splicing PMID: 29230097
2. Authors show here USP2 is expressed in quiescent and activated T-cells and its expression is 50% lower in CTCL cell lines (MyLa2000, SeAx and Hut-78) than in normal T-cells. PMID: 27351221
3. The results show a connection between miR-125b and USP2 gene the etiology of psoriasis. They proceeded to show that modulation of nuclear factor kappa B-mediated inflammation is the likely mechanism through which this miRNA gene pair function PMID: 27479112
4. the deubiquitinase USP2a translocates into the nucleus and binds to pY701-STAT1, and inhibits K48-linked ubiquitination and degradation of pY701-STAT1 PMID: 27434509
5. ML364 also caused a decrease in homologous recombination-mediated DNA repair. These effects by a small molecule inhibitor support a key role for USP2 as a regulator of cell cycle, DNA repair, and tumor cell growth. PMID: 27681596
6. Identify USP2 as a novel regulator of lipoprotein clearance owing to its ability to control ubiquitylation-dependent degradation of the LDLR by IDOL. PMID: 26666640
7. Data suggest up-regulation of ASAH1 (acid ceramidase) activity by androgen in androgen-sensitive prostate cancer cells (but not other cancer cells) is mainly due to prolonged stability of ASAH1 by androgen-stimulated induction of USP2 expression. PMID: 25888580
8. Modulation of USP-2 expression plays a crucial role in cell cycle regulation by leptin and adiponectin. PMID: 26033248
9. Our findings suggest that USP2a mRNA may be considered as a diagnostic marker candidate for bladder cancer, in particular, to stratify MIBC patients with a more invasive phenotype. PMID: 26250800
10. The present study showed that USP2 expression is associated with TNBC cell line's invasiveness and poor survival of breast cancer patients and may serve as a prognostic biomarker and therapeutic target for TNBC PMID: 25687182
11. findings demonstrated that USP2b deubiquitinates K63-linked polyubiquitin chains from TBK1 to terminate TBK1 activation and negatively regulate IFN-beta signaling and antiviral immune response. PMID: 25070846
12. Loss of USP2a expression is associated with glioblastoma. PMID: 24445145
13. USP2a increases intracellular glutathione content, thus interfering with the oxidative cascade triggered by chemotherapeutic agents. PMID: 24071644
14. USP2 and its substrate, fatty acid synthase (FASN), are over-expressed in glioma tissue. PMID: 23416128
15. we have demonstrated that USP2a plays a negative regulatory role in IL-1beta- and SeV-induced NF-kappaB activation. PMID: 22611252
16. USP2a plays an important role in TCR signaling by deSUMOylating TRAF6 and mediating TRAF6-MALT1 interaction PMID: 23264041
17. USP2a antagonizes EGFR endocytosis and thus amplifies signaling activity from the receptor. PMID: 22710717
18. TRAF2 inhibits USP2a effect on K48- but not on K63-linked ubiquitin chains. PMID: 22659130
19. USP2a potentially mediates circadian disruption by suppressing the CRY1 degradation during inflammation. PMID: 22669941
20. USP2a loss attenuates proliferation and migration in T24 human bladder cancer cells. PMID: 22370483
21. a novel mechanism for the role of USP2a in mediating the stability of Aurora-A. PMID: 21890637
22. Data indicate that CHIP and USP2 show antagonistic functions in the control of AIF-mediated cell death, and implicate the role of the enzymes as a switch for cells to live or die under stresses that cause truncated AIF release. PMID: 21293491
23. Etiology of nodular fasciitis seems to involve USP6 transcriptional upregulation due to its fusion with a strong ectopic promoter (MYH9). PMID: 21826056
24. the data support the conclusion that Usp2-45 action on epithelial Na(+) channel is promoted by various interactions, including through binding to Nedd4-2 PMID: 21478478
25. our results implicate USP2 as a novel positive regulator of TNF-alpha-induced NF-kappaB signaling and show that its expression is altered in tumor cells. PMID: 21480224
26. USP2-69 was upregulated in mesangial cells during mesangial proliferative glomerulonephritides in vivo and in vitro, which may relate to the proliferation of mesangial cells. PMID: 20403044
27. Data show that ectopic expression of wild-type USP2a but not a catalytic mutant prevents Mdm2-mediated degradation of MdmX. PMID: 19838211
28. Overexpression of Ubp41 is sufficient to elicit all features of apoptosis in human cells. PMID: 12566314
29. the isopeptidase USP2a plays a critical role in prostate cancer cell survival PMID: 15050917
30. USP2a is a novel regulator of the p53 pathway that acts through its ability to selectively target Mdm2. PMID: 17290220
31. USP2 were over-expressed in ovarian serous cystadenocarcinoma tissues, suggesting that the activity of ubiquitin-proteasome system is obviously enhanced in ovarian cancer. PMID: 17553343
32. Findings suggest that targeting USP2 is an effective approach to induce growth suppression in the cancer cells addicted to cyclin D1 expression. PMID: 19917254

Show More

Hide All

HGNC: 12618

OMIM: 604725

KEGG: hsa:9099

STRING: 9606.ENSP00000260187

UniGene: Hs.524085